94984 ⎘
Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms One oxygen atom, e.g. butenolide
DEUTERIUM-LABELLED CANNALACTONE SYNTHESIS AND USE FOR THE DOSAGE OF CANNALACTONE IN ALL TISSUES OR EXUDATES OF LIVING PLANTS OR ORGANISMS
#2SESTERTERPENOID COMPOUNDS AND EXTRACT L01 OF LEUCOSCEPTRUM CANUM, AND USE THEREOF IN TREATMENT OF PSORIASIS
#3PROCESS FOR THE SYNTHESIS OF SUBSTITUTED TETRAHYDROFURAN MODULATORS OF SODIUM CHANNELS
#4COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME
#5COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION
#6Covalent Inhibitors As Antiviral Agents
#7A method for asymmetric synthesis of (-)- Anisomelic Acid
#8USE OF 5-METHYL-5-(4-METHYL-3-PENTEN-1-YL)-2(5H)-FURANONE AS AROMA CHEMICAL
#9Method for Producing alpha-Methylene-Lactones
#10GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM
#11NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES
#12Compositions and methods for viral sensitization
#13COMPOUND AND DETERGENT COMPOSITION
#14Synthesis of alkynones via carbonylative Sonogashira coupling reactions catalyzed by Pd(II)-N-Heterocyclic carbene-pyridine complexes
#15N-benzyl-2-phenoxybenzamide derivatives as prostaglandin E2 (PGE2) receptors modulators
#16Use of functionalized alpha-angelica lactones
#17Modified metal-organic framework and catalyst for hydrogenation reaction including same
#18Functionalized α-angelica lactone monomers and polymers obtained therefrom
#19ESTER NITRATES DERIVATIVES OF AROMATIC ALDEHYDES WITH MULTIPLE PHARMALOGIC PROPERTIES TO TREAT SICKLE CELL DISEASE
#20Andrographolide compound and method for treatment or prevention of fibrotic disease using the same
#21Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease
#22Compositions and methods for viral sensitization
#23Cyclization processes of hydroxyalkenoic acids and products thereof
#24Plant growth regulator compounds
#25METHOD FOR CONVERTING LEVOGLUCOSENONE INTO 4-HYDROXYMETHYL BUTYROLACTONE AND 4-HYDROXYMETHYL BUTENOLIDE WITHOUT USING ANY ORGANIC SOLVENT AND CATALYST
#26Methods of forming aromatic containing compounds
#27COMPOSITIONS AND METHODS FOR ENHANCING ONCOLYTIC VIRUS EFFICACY
#28Stereoselective process
#29Compositions and methods for viral sensitization
#30Process for treating homoserine-based compound
#315H-furan-2-one derivatives stabilization of organic material
#32TOFA analogs useful in treating dermatological disorders or conditions
#33Use of 15-benzylidence-14-deoxy-11, 12 -dehyroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virus
#34GASOLINE PREPARED FROM BIOMASS-DERIVED LEVULINIC ACID
#35Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease
#36Low-toxicity olefinic ester compositions and methods of using the same
#37Method for the isomerisation of glucose
#38Strigolactone analogues and their use
#39Compositions and methods for enhancing virus efficacy
#40Strigolactone analogues and the use thereof for the treatment of plants
#41Ascorbic acid salt of sunitinib
#42LABDANE DITERPENOID COMPOUNDS, SEMEN BIOTAE EXTRACT, AND PREPARATION METHOD AND USE THEREOF
#43Production Method of a-Methylene Lactone
#44Use of 15-benzylidene-14-deoxy-11, 12-dehydroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virus
#45TOFA analogs useful in treating dermatological disorders or conditions
#46PROCESS FOR PREPARING CEPHALOTAXINE ESTERS
#47Radical inhibitor
#48Strigolactone analogues and their use
#49C-9 oxygen functionalized labdane derivates
#505H-furan-2-one derivatives for stabilization of organic material
#51Fulvene and fulvalene analogs and their use in treating cancers
#52Process for the conversion of a carbohydrate-containing feedstock
#53Hydrogenation of esters or carbonyl groups with tetradentate amino/imino-thioether based ruthenium complexes
#54Substituted heterocyclic compounds for disease treatment
#55Bis-phosphate compound and asymmetric reaction using the same
#56Dihydrofuran derivatives as insecticidal compounds
#57Pyridazine derivatives, processes for their preparation and their use as fungicides
#58Natural gas odorization
#59NOVEL COMPOUNDS AS MODULATORS OF GLUCOCORTICOID RECEPTORS
#60Process for synthesizing epicconone analogs
#61Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
#62TOFA analogs useful in treating dermatological disorders or conditions
#63Structure and method for synthesizing and using dialkyl(2,4,6- or 2,6-alkoxyphenyl)phosphine and its tetrafluoroborate
#64Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and oriented film
#65Lactone compounds and materials made therefrom
#66Compositions and methods for enhancing virus efficacy
#67TRP-P8 ACTIVE COMPOUNDS AND THERAPEUTIC TREATMENT METHODS
#68PROCESS FOR PREPARING CEPHALOTAXINE ESTERS
#69Tautomycetin and tautomycetin analog biosynthesis
#70Tautomycetin and tautomycetin analog biosynthesis
#71Enaminocarbonyl compounds and their use
#72Isomerization of sugars
#73Methylene furanone derivatives and use of said derivatives as a photoprotecting or antioxidant or depigmentation agent in cosmetic or dermatological compositions
#74POLYESTERS, POLYURETHANES AND PROCESS FOR THEIR PRODUCTION
#75Process for the oxidation of alcohol and/or aldehyde groups
#76Lactone formulations and method of use
#77Compound comprising triarylamine moieties and a condensed ring moiety, and the production method thereof
#78Andrographolide derivatives and use thereof in manufacture of medicaments
#79Inotilone derivatives as coherent biological response modifier (cBMR)
#80Flavorant and Fragrance Furan-2(5H)-One Compounds
#81Oxime ether derivative and fungicide for agricultural and horticultural use
#82Prodrugs of GABA analogs, compositions and uses thereof
#83In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
#84LABELING AND DETECTION OF NUCLEIC ACIDS
#85Method for producing 4-aminobut-2-enolides
#86Curcumin analogues and uses thereof
#87Hydrogen odorization
#88Anti-fatigue agents and oral compositions containing andrographolide as active ingredient
#89Bifunctional polymerizable compound, polymerizable liquid crystal composition, and oriented film
#90Furanone compounds and lactam analogues thereof
#91Furanone endcapped polymers
#92Method for producing cyclic unsaturated compound
#93Non-amphiphile-based water-in-water emulsion and uses thereof
#94NITROSATED AND NITROSYLATED CYCLOOXYGENASE-2 INHIBITORS, COMPOSITIONS AND METHODS OF USE
#95Allylic oxidations catalyzed by dirhodium catalysts under aqueous conditions
#96Polymerziable liquid crystal compound, polymerziable liquid crystal composition comprising the same, and polymer produced using them
#97CATALYTIC ANTIOXIDANTS AND METHODS OF USE
#98Dosing Regimens for Cox-2 Inhibitor
#99FULVENE AND FULVALENE ANALOGS AND THEIR USE IN TREATING CANCERS
#100Production of Furanones
#101NOVEL CURCUMIN ANALOGUES AND USES THEREOF
#102Curcumin analogues and uses thereof
#103Decahydronaphthalene compounds
#104Labeling and detection of nucleic acids
#105Selective Cox-2 Inhibitors
#106Association of Antimicrobial Compounds with Surfaces and Polymers
#107Compounds with antifungal properties and process thereof
#108Derivatives of sulindac, use thereof and preparation thereof
#109SMALL-MOLECULES FOR TREATING CANCER AND ABNORMAL CELL PROLIFERATION DISORDERS
#110SOLID-STATE FORM OF CELECOXIB HAVING ENHANCED BIOAVAILABILITY
#111Hypoglycemic agent
#112Hypoglycemic agent
#113Hypoglycemic agent
#114Process for production of amines
#115Supercritical fluid phase synthesis of methylene lactones using catalysts derived from hydrotalcites
#116Catalytic antioxidants and methods of use
#117Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
#118Production of furanones
#119Prodrugs of GABA analogs, compositions and uses thereof
#120Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one useful in the preparation of the DPP-IV inhibitor (S)-1 ((2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7, 11b-hexahydro-2H-pyrido[2,1-a] isoquinolin-3-yl)-4-fluoromethyl-pyrrolidin-2-one
#121Novel compounds, pharmaceutical compositions containing same, and methods of use for same
#122Structural carotenoid analogs for the inhibition and amelioration of disease
#1233-Phenylfuran-2-one derivatives as cox-2 inhibitor
#124Opioid receptor antagonists
#125Combretastatin derivatives with cytotoxic action
#126Isophthalic acid derivatives
#127Vitamin Dlactone derivatives
#128Gas phase synthesis of methylene lactones using catalysts derived from hydrotalcite precursors
#129N-protected/N-substituted-beta-amino hydroxy sulfonates
#1302,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
#131Lactone derivative and its manufacturing method
#132Gas phase synthesis of methylene lactones using novel catalyst
#133Gas phase synthesis of methylene lactones using novel grafted catalyst
#134Liquid phase synthesis of methylene lactones using novel catalyst
#135Supercritical fluid phase synthesis of methylene lactones using oxynitride catalyst
#136Supercritical fluid phase synthesis of methylene lactones using novel catalyst field of invention
#137Liquid phase synthesis of methylene lactones using novel grafted catalyst
#138Gas phase synthesis of methylene lactones using oxynitride catalyst
#139Supercritical fluid phase synthesis of methylene lactones using novel grafted catalyst
#140Liquid phase synthesis of methylene lactones using oxnitride catalyst
#141Pharmaceutical compounds that regenerate in vivo
#142Preparation of 4-substituted-2-buten-4-olides from mucohalic acids
#143Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
#144Solid-state form of celecoxib having enhanced bioavailability
#145Lactone formulations and method of use
#146Curcumin analogues and uses thereof
#147Modulators of the glucocorticoid receptor and method
#148Medicinal composition for diagnosis, prevention, or therapy of multiple risk factor syndrome
#149Carotenoid ether analogs or derivatives for controlling connexin 43 expression
#150Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
#151Preparation of aryl-substituted butenolides using mucohalic acids
#152Hypoglycemic agent
#153Carotenoid analogs or derivatives for the inhibition and amelioration of disease
#154Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
#155Vitamin d3 derivatives and remedies using the same
#156Trp-p8 active compounds and therapeutic treatment methods
#157Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
#158Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease
#159Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
#160Carotenoid ether analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
#161Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
#162Carotenoid analogs or derivatives for controlling C-reactive protein levels
#163Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
#164Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
#165Separation of compounds using tagging moieties including varying numbers of repeat units
#166Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
#167Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors
#168Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
#169Carotenoid analogs or derivatives for controlling expression
#170Carotenoid ester analogs or derivatives for controlling connexin 43 expression
#171Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
#172Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease